En un hito histórico para la medicina, la primera vacuna contra el cáncer de pulmón ha comenzado a ser ensayada en siete ...

Las acciones de Pfizer cotizan y se negocian en la bolsa de valores Nueva York. ¿Cuál es el símbolo bursátil de Pfizer? El símbolo bursátil de Pfizer es “PFE”. ¿Paga Pfizer dividendos?

Para el director de Pfizer, un elemento clave para convencer al corporativo de que nuestro país es una buena opción para invertir es la investigación clínica, de ahí que el laboratorio tiene ...

Pfizer has ended development of a B7-H4-directed antibody-drug conjugate (ADC), triggering a $1 billion impairment charge. The Big Pharma disclosed the blow alongside a $200 million charge linked ...

After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely in the past.” In an investor presentation (PDF) Tuesday ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so that physicians would prescribe a specific migraine drug to patients ...

Polémica Pfizer y el ocultamiento de datos sobre el Alzheimer: ¿verdad o mentira? Hace unos días, el diario Washington Post publicó una investigación que generó muchísima polémica: que el laboratorio ...

Es importante destacar que uno de los puntos centrales de la estrategia de Pfizer es su robusto pipeline de investigación clínica. Tecnologías disruptivas como el ARN mensajero (ARNm), que ...

Merck is battling selling pressure, but strong analyst targets suggest upside potential. Pfizer faces a bearish trend with minimal upside, though analysts expect a moderate gain. Get two weeks of ...

Activist Starboard Value has decided not to pursue a proxy battle with Pfizer. Starboard built a $1 billion stake in Pfizer in October and reportedly planned to push for changes. Get two weeks of ...

Ahead of next Tuesday's earnings release, Pfizer seems undervalued based on current price of $26.55 & valuation of $150bn. But is it madness to expect upside? Quite possibly it is. My DCF analysis ...

Recently, Pfizer found itself in the agency's crosshairs thanks to one of its M&A plays. Now, Pfizer—which purchased neuroscience specialist Biohaven for $11.6 billion in 2022—is committing ...